Single-nucleotide polymorphisms in the p53 pathway

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 70, Issue , 2005, Pages 111-119

  Harris, S L ^a   Gil, G ^a   Hu, W ^a   Robins, H ^b   Bond, E ^a   Hirshfield, K ^a   Feng, Z ^a   Yu, X ^a   Teresky, A K ^a   Bond, G ^b   Levine, A J ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b INSTITUTE FOR ADVANCED STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; B LYMPHOCYTE; CELL CULTURE; CELL LINE; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; GAMMA RADIATION; GENE EXPRESSION; GENETIC HETEROGENEITY; HAPLOTYPE; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS TRANSFORMATION; WESTERN BLOTTING; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENE SILENCING; GENOTYPE; PHENOTYPE; PROTEIN ANALYSIS; RNA ANALYSIS; TUNEL ASSAY;

AFRICAN AMERICANS; APOPTOSIS; CELL LINE, TRANSFORMED; DNA DAMAGE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GAMMA RAYS; GENES, P53; GENES, TUMOR SUPPRESSOR; HAPLOTYPES; HUMANS; MALE; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

HUMAN HERPESVIRUS 4;

EID: 33746435256     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2005.70.024     Document Type: Conference Paper

References (31)

1. Appella E. and Anderson C.W. 2001. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268: 2764.
2. Attardi L.D., Reczek E.E., Cosmas C., Demicco E.G., McCurrach M.E., Lowe S.W., and Jacks T. 2000. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 14: 704.
3. Beckman G., Birgander R., Sjalander A., Saha N, Holmberg P.A., Kivela A., and Beckman L. 1994. Is p53 polymorphism maintained by natural selection? Hum. Hered. 44: 266.
4. Bellacosa A., Testa J.R., Moore R., and Larue L. 2004. A portrait of AKT kinases: Human cancer and animal models depict a family with strong individualities. Cancer Biol. Ther. 3: 268.
5. Camplejohn R.S. and Rutherford J. 2001. p53 functional assays: Detecting p53 mutations in both the germline and in sporadic tumours. Cell Prolif. 34: 1.
6. Camplejohn R.S., Sodha N., Gilchrist R., Lomax M.E., Duddy P.M., Miner C., Alarcon-Gonzalez P., Barnes D.M., and Eeles R.A. 2000. The value of rapid functional assays of germline p53 status in LFS and LFL families. Br. J. Cancer 82: 1145.
7. Camplejohn R.S., Gilchrist R., Easton D., McKenzie-Edwards E., Barnes D.M., Eccles D.M., Ardern-Jones A., Hodgson S.V., Duddy P.M., and Eeles R.A. 2003. Apoptosis, ageing and cancer susceptibility. Br. J. Cancer 88: 487.
8. Donehower L.A., Harvey M., Vogel H., McArthur M.J., Montgomery C.A., Jr., Park S.H., Thompson T., Ford R.J., and Bradley A. 1995. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol. Carcinog. 14: 16.
9. Dumont P., Leu J.I., Della Pietra A.C., III, George D.L., and Murphy M. 2003. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 33: 357.
10. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., and Gogos J.A. 2004. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 36: 131.
11. Feng J., Tamaskovic R., Yang Z., Brazil D.P., Merlo A., Hess D., and Hemmings B.A. 2004. Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation. J. Biol. Chem. 279: 35510.
12. Gottlieb T.M., Leal J.F., Seger R., Taya Y., and Oren M. 2002. Cross-talk between Akt, p53 and Mdm2: Possible implications for the regulation of apoptosis. Oncogene 21: 1299.
13. Hinds D.A., Stuve L.L., Nilsen G.B., Halperin E., Eskin E., Ballinger D.G., Frazer K.A., and Cox D.R. 2005. Whole-genome patterns of common DNA variation in three human populations. Science 307: 1072.
14. Hwang S.J., Lozano G., Amos C.I., and Strong L.C. 2003. Germline p53 mutations in a cohort with childhood sarcoma: Sex differences in cancer risk. Am. J. Hum. Genet. 72: 975.
15. Ihrie R.A. and Attardi L.D. 2004. Perp-etrating p53-dependent apoptosis. Cell Cycle 3: 267.
16. Ihrie R.A., Reczek E., Horner J.S., Khachatrian L., Sage J., Jacks T., and Attardi L.D. 2003. Perp is a mediator of p53-dependent apoptosis in diverse cell types. Curr. Biol. 13: 1985.
17. Ihrie R.A., Marques M.R., Nguyen B.T., Horner J.S., Papazoglu C., Bronson R.T., Mills A.A., and Attardi L.D. 2005. Perp is a p63-regulated gene essential for epithelial integrity. Cell 120: 843.
18. Jin S. and Levine A.J. 2001. The p53 functional circuit. J. Cell Sci. 114: 4139.
19. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K., Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P., McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., and Naylor J., et al. (International Human Genome Sequencing Consortium). 2001. Initial sequencing and analysis of the human genome. Nature 409: 860.
20. Li F.P. 1990. Familial cancer syndromes and clusters. Curr. Probl. Cancer 14: 73.
21. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., and Jacks T. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847.
22. Malkin D., Li F.P., Strong L.C., Fraumeni J.F., Jr., Nelson C.E., Kim D.H., Kassel J., Gryka M.A., Bischoff F.Z., and Tainsky M.A., et al. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-8.
23. Marin M.C., Jost C.A., Brooks L.A., Irwin M.S., O'Nions J., Tidy J.A., James N., McGregor J.M., Harwood C.A., Yulug I.G., Vousden K.H., Allday M.J., Gusterson B., Ikawa S., Hinds P.W., Crook T., and Kaelin W.G., Jr. 2000. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat. Genet. 25: 47.
24. Mayo L.D. and Donner D.B. 2001. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. 98: 11598.
25. Nowak M., Koster C., and Hammerschmidt M. 2005. Perp is required for tissue-specific cell survival during zebrafish development. Cell Death Differ. 12: 52.
26. Ogawara Y., Kishishita S., Obata T., Isazawa Y., Suzuki T., Tanaka K., Masuyama N., and Gotoh Y. 2002. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J. Biol. Chem. 277: 21843.
27. Sachidanandam R., Weissman D., Schmidt S.C., Kakol J.M., Stein L.D., Marth G., Sherry S., Mullikin J.C., Mortimore B.J., Willey D.L., Hunt S.E., Cole C.G., Coggill P.C., Rice C.M., Ning Z., Rogers J., Bentley D.R., Kwok P.Y., Mardis E.R., Yeh R.T., Schultz B., Cook L., Davenport R., Dante M., and Fulton L., et al. (International SNP Map Working Group). 2001. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409: 928.
28. Soussi T. and Beroud C. 2001. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat. Rev. Cancer 1: 233.
29. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J., Gabor Miklos G.L., and Nelson C., et al. 2001. The sequence of the human genome. Science 291: 1304.
30. Vogelstein B., Lane D., and Levine A.J. 2000. Surfing the p53 network. Nature 408: 307.
31. Zhou B.P., Liao Y., Xia W., Zou Y., Spohn B., and Hung M.C. 2001. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3: 973.